Q1 2019 EPS Estimates for Bausch Health Companies Inc Lowered by Analyst (BHC)

Bausch Health Companies Inc (TSE:BHC) – Equities researchers at Piper Jaffray Companies cut their Q1 2019 EPS estimates for shares of Bausch Health Companies in a research note issued to investors on Wednesday, February 20th. Piper Jaffray Companies analyst D. Amsellem now forecasts that the company will post earnings of $1.03 per share for the quarter, down from their prior forecast of $1.06. Piper Jaffray Companies also issued estimates for Bausch Health Companies’ Q3 2019 earnings at $1.32 EPS, FY2019 earnings at $5.12 EPS, Q2 2020 earnings at $1.45 EPS, Q3 2020 earnings at $1.47 EPS and Q4 2020 earnings at $1.58 EPS.

Separately, BMO Capital Markets lowered their price objective on Bausch Health Companies from C$26.00 to C$25.00 in a research report on Thursday.

BHC opened at C$31.20 on Thursday. The firm has a market cap of $11.06 billion and a P/E ratio of -3.34. Bausch Health Companies has a 12 month low of C$18.62 and a 12 month high of C$36.52. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 764.01.

Bausch Health Companies Company Profile

Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It offers dermatology products that treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis, cold sores, athlete's foot, nail fungus, and other dermatoses, as well as provides aesthetic medical devices, which address various conditions, including facial wrinkles, acne, pigmentation conditions, body sculpting, skin tightening, and laser hair removal.

Further Reading: What type of investment options does a Roth IRA provide?

Earnings History and Estimates for Bausch Health Companies (TSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.